| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12,324 |
10,808 |
$952K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,647 |
15,486 |
$671K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
31,922 |
8,965 |
$560K |
| 93229 |
|
930 |
874 |
$352K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,744 |
3,258 |
$285K |
| 99222 |
Initial hospital care, per day, moderate complexity |
6,726 |
5,658 |
$257K |
| 93970 |
|
2,300 |
1,998 |
$239K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,669 |
6,630 |
$174K |
| 93925 |
|
1,583 |
1,294 |
$109K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
596 |
532 |
$88K |
| 93015 |
|
1,335 |
1,218 |
$86K |
| 93351 |
|
805 |
622 |
$57K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
324 |
301 |
$45K |
| 97597 |
|
2,934 |
1,456 |
$39K |
| 93458 |
|
341 |
234 |
$33K |
| J2785 |
Injection, regadenoson, 0.1 mg |
379 |
356 |
$28K |
| 93000 |
|
1,696 |
1,534 |
$26K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
892 |
597 |
$22K |
| 93224 |
|
192 |
166 |
$15K |
| 93228 |
|
922 |
867 |
$14K |
| 93280 |
|
627 |
520 |
$13K |
| 93923 |
|
369 |
257 |
$12K |
| 93880 |
|
129 |
116 |
$11K |
| 36247 |
|
100 |
44 |
$10K |
| 99490 |
Ccm add 20min |
1,650 |
1,349 |
$9K |
| 99223 |
Prolong inpt eval add15 m |
126 |
116 |
$8K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
137 |
84 |
$8K |
| 75625 |
|
47 |
42 |
$6K |
| 99219 |
|
130 |
118 |
$5K |
| 36200 |
|
85 |
70 |
$4K |
| 75716 |
|
31 |
29 |
$4K |
| 99152 |
|
227 |
151 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
75 |
55 |
$3K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
213 |
106 |
$2K |
| 95806 |
|
18 |
17 |
$2K |
| 93248 |
|
150 |
120 |
$2K |
| 93299 |
|
175 |
159 |
$2K |
| 93297 |
|
216 |
211 |
$2K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
238 |
230 |
$1K |
| 99205 |
Prolong outpt/office vis |
37 |
12 |
$1K |
| 93244 |
|
70 |
68 |
$1K |
| 93246 |
|
150 |
120 |
$963.07 |
| 99153 |
Mod sedat endo service >5yrs |
139 |
87 |
$887.31 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
196 |
172 |
$827.06 |
| 99225 |
|
21 |
13 |
$727.04 |
| 99233 |
Prolong inpt eval add15 m |
25 |
14 |
$712.97 |
| 93971 |
|
17 |
13 |
$709.43 |
| 93242 |
|
70 |
68 |
$632.80 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
149 |
76 |
$624.82 |
| 76937 |
|
50 |
45 |
$318.97 |
| 93308 |
|
13 |
12 |
$281.49 |
| 93285 |
|
12 |
12 |
$243.96 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
218 |
180 |
$204.88 |
| 0298T |
|
249 |
240 |
$196.23 |
| 0296T |
|
249 |
240 |
$163.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
260 |
164 |
$144.49 |
| J1245 |
Injection, dipyridamole, per 10 mg |
84 |
77 |
$140.10 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
168 |
102 |
$33.29 |